Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.
Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations
The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.
EVEN MORE SEMINARS
Prof Jenny Freeman University of Plymouth
Physiotherapy research in MS: An overview and reflections on the clinical implications?
Prof Sara Demain University of Plymouth
Philippe AUVRAY NEURALLYS
Ambulatory Intracranial pressure monitoring: a revolution for shunted patients and neurosurgeons
Dr Michael J. Grey University of East Anglia
Effecting neuroplasticity with virtual rehabilitation
Mark Timmins St James’s Place Wealth Management
Pension annual and lifetime allowance; what you need to know.